Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND The impact of body composition on outcomes after surgery for colorectal liver metastases (CRLM) remains unclear. The aim of the present study was to determine the influence of sarcopenia, obesity and sarcopenic obesity on morbidity, disease-free (DFS) and overall survival (OS). METHOD Between 2005 and 2012, all patients undergoing a partial liver resection for CRLM in the Maastricht University Medical Centre, and who underwent computed tomography (CT) imaging within 3 months before liver surgery, were included. Body composition was primarily based on pre-operative CT measurements. Sarcopenia was based on total muscle area at the level of the third lumbar vertebra and predefined body mass index (BMI)- and gender-specific cut-off values for sarcopenia were used. Body fat percentages were calculated and the top 40% for men and women were considered obese. RESULTS Of the 171 included patients undergoing liver surgery for CRLM, 80 (46.8%) patients were sarcopenic, 69 (40.4%) obese and 49 (28.7%) sarcopenic obese. The presence of sarcopenia, obesity or sarcopenic obesity did not affect the complication rates. However, readmission rates were significantly increased in patients with (sarcopenic) obesity (P < 0.05). Surprisingly, obesity seemed to prolong OS (P = 0.021) and was identified as an independent predictor [hazard ratio (HR):0.58 and P = 0.046] for better OS. Sarcopenia and sarcopenic obesity did not affect DFS or OS. CONCLUSION Sarcopenia, obesity and sarcopenic obesity did not worsen DFS, OS and complication rates after a partial liver resection for CRLM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 1×
“Moreover, we based sarcopenia on CT-based measurements, the gold standard for estimating muscle mass.(37) The main drawbacks, however, of the present study are the retrospective design and the calculation of percentage body fat.”
MethodEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“, using dual-energy X-ray (DXA), revealed an incidence of sarcopenia of about 20% in patients <70 years of age rising to over 50% in patients aged >80 years in a healthy population.(31) It should be realized that cachexia (cancerrelated loss of adipose tissue and skeletal muscle mass) also contributes to muscle wastin…”
MethodPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589
The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery
Stockmann, M., Lock, J. F., Malinowski, M., Niehues, S. M., Seehofer, D., & Neuhaus, P. (2010) · HPB · doi:10.1111/j.1477-2574.2009.00151.x · Cited by 260
Cited by
Pamoukdjian, F., Bouillet, T., Lévy, V., Soussan, M., Zelek, L., & Paillaud, E. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.07.010 · Cited by 387
Simonsen, C., de Heer, P., Bjerre, E. D., Suetta, C., Hojman, P., Pedersen, B. K., Svendsen, L. B., & Christensen, J. F. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002679 · Cited by 375
Baracos, V. E., & Arribas, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx810 · Cited by 362
“Definitions of obesity were variously BMI 30, 27 or 25 kg/m(2), visceral fat area [22] or body fat % [23].”
BackgroundComputed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
Kazemi-Bajestani, S. M. R., Mazurak, V. C., & Baracos, V. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.09.001 · Cited by 313
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
Prado, C. M., Cushen, S. J., Orsso, C. E., & Ryan, A. M. (2016) · Proceedings of the Nutrition Society · doi:10.1017/s0029665115004279 · Cited by 300
Metadata
- Authors
- Lodewick, T. M., van Nijnatten, T. J. A., van Dam, R. M., van Mierlo, K., Dello, S. A. W. G., Neumann, U. P., Olde Damink, S. W. M., & Dejong, C. H. C.
- Venue
- HPB
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 17
- Issue
- 5
- Pages
- 438-446
- ISSN
- 1365-182X (ISSN-L)
- OpenAlex
- W2141472964
- Cited by
- 129
- References
- 8
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? https://app.cochat.ai/papers/10.1111/hpb.12373
- The paper
- Lodewick, T. M., van Nijnatten, T. J. A., van Dam, R. M., van Mierlo, K., Dello, S. A. W. G., Neumann, U. P., Olde Damink, S. W. M., & Dejong, C. H. C. (2015). Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB. https://doi.org/10.1111/hpb.12373
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.